Viewing Study NCT02773550


Ignite Creation Date: 2025-12-24 @ 5:10 PM
Ignite Modification Date: 2025-12-27 @ 10:41 AM
Study NCT ID: NCT02773550
Status: TERMINATED
Last Update Posted: 2020-01-18
First Post: 2015-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma
Sponsor: Basque Health Service
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module